Oct. 17, 2024
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures submitted a letter to five of the seven Medicare administrative contractors (MACs) their final local coverage determination (LCD) on Trigger Point Injections (TPI). Celerian Group Company Administrators, LLC, Noridian Healthcare Solutions, LLC, National Government Services, Inc., Palmetto GBA and Wisconsin Physicians Service Insurance Corporation deem ultrasound guidance for TPIs as investigational because of a lack of evidence of enhanced safety.

The specialty societies encourage these MACs to review new guidelines that support the use of ultrasound guidance for TPIs in specific anatomic locations. Without ultrasound guidance availability, diagnostic relevance is lost and the safety of certain TPI injections (e.g., anterior neck muscles, deep gluteal muscles, chest wall) are greatly reduced.

The ACR Contractor Advisory Committee (CAC) Network representatives relayed their concerns about this adverse LCD in March.

For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.

Related ACR News

  • Bill Introduced to Expand Access to Lung Cancer Screening

    The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the HRSA, with an emphasis on lung cancer.

    Read more
  • ACR Urges HHS to Promote Annual Lung Cancer Screenings

    In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening.

    Read more
  • FDA Approves Alternative Standard Breast Density Reporting

    The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.

    Read more